Positive drug purchase new regulatory difficulties of payment, pharmaceutical companies Pharmaceutical Industry concerns – drug procurement, back section – the pharmaceutical industries

Reform of the new channels for medical reform, "Back to the article" storm

Recent introduction of the "7 article," precept, so that a large number of small and medium Medicine Wholesalers felt dejected?? Previous layers of overweight such as eating hormone puffiness of the pharmaceutical business chain, was cut into pharmaceutical companies, distribution companies and hospitals in the interests of kink along with a "three-section cudgel", channel integration in the grind and struggle, may started from July.

New medical reform the whole idea of "big production", "big circulation", a direct positive large pharmaceutical commercial enterprises. But pharmaceutical companies also felt the disturbance had been Sell "Back to the article" The pressure has been simplified channel chain increased. Previously, due to payment arrears led to hospitals and distributors Pharmacy Industrial assembly line can not start a frequent phenomenon.

To leveling selling "Back to the article" obstacles, drug manufacturers to seek appropriate medical clues commercial companies desire to thrive.

VS provincial and municipal giant pharmaceutical companies: an asymmetrical battle

In drug procurement, "two votes" system implemented after the interests of three parties: the hospital, circulation, security providers and pharmaceutical companies profit maneuvers decreases, many large pharmaceutical companies are seeking to own or control the retail terminal. Beijing Vocational College of Finance and Trade Researcher Lai Yang said, "the behavior of large pharmaceutical companies, not just to return to the rapid section, the two-vote system for level coded channels to reduce the price, they must ensure that the rate of self-profit." Recently, the U.S. pharmaceutical

health action to doing these judgments footnote: Health U.S. joint Xinkaihe, with the same medicine [18.980.69%] Cooperation , And Nepstar cooperation in an attempt to improve distribution channels and expand capacity, reduce cost of sales, harvest Chinese Herbal Medicine Each chain link of the profits, while the Shanghai Fuxing holdings have also been the retail terminal Tongjitang shares, want to integrate the two Chinese assets.

At the same time, circulation of the national health care reform focused on completed at the municipal, medical integration of provincial channels are open big mouth.

Last month, the Henan Provincial Government and the China Medical Group, a high-profile signing of cooperation agreements in Zhengzhou, Zhengzhou Medical Sinopharm restructuring. By the industry as the "Zhengzhou Model" Chinese online distribution will also be in accordance with the agreement is to promote the province, the provincial focus on accelerating the pace.

Fujian provincial channels of Chinese medicine in Fujian province with the Spring distribution to achieve a full coverage, and net sales in the distribution of hospitals in Fuzhou, the absolute leading position occupied it in the Fuzhou market share to nearly 50% The second, a far cry from his three.

Guangzhou Pharmaceutical Co., Ltd. has begun moves to sell the company is pressing ahead with policy changes, many large pharmaceutical companies in Guangdong has acquired a large area of SMEs, to expand distribution capacity.

Hospital system doing? They sat side curtain, waiting for cranes after quarrel third party to join.

I am China Suppliers writer, reports some information about electric food warmer , furnace gas valve.

Processing your request, Please wait....

Leave a Reply